Tenet Healthcare (THC)
(Delayed Data from NYSE)
$156.57 USD
-0.17 (-0.11%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $156.69 +0.12 (0.08%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth C Momentum A VGM
Price, Consensus and EPS Surprise
THC 156.57 -0.17(-0.11%)
Will THC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for THC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for THC
Tenet Healthcare (THC) Stock Declines While Market Improves: Some Information for Investors
Inogen Stock Rises 47% in 6 Months: What's Driving the Rally?
THC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio
Should SPDR S&P 400 Mid Cap Value ETF (MDYV) Be on Your Investing Radar?
Glaukos Stock Soars 59.2% Year to Date: What's Behind the Rally?
Other News for THC
Hedge funds pile into healthcare stocks amid dip, Goldman Sachs says
JMEE: Actively Managed ETF In Line With Its Objective
Women Face Criminal Charges Over Pregnancy For Medical Cannabis Use, Record Number Of Prosecutions In Year After Dobbs
15 Analysts Assess Tenet Healthcare: What You Need To Know
Tenet Completes Sale of Five Hospitals in Birmingham